Adalimumab for maintenance of remission in Crohn's disease

BACKGROUND: Conventional medications for Crohn's disease (CD) include anti‐inflammatory drugs, immunosuppressants and corticosteroids. If an individual does not respond, or loses response to first‐line treatments, then biologic therapies such as tumour necrosis factor‐alpha (TNF‐α) antagonists...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Townsend, Cassandra M, Nguyen, Tran M, Cepek, Jeremy, Abbass, Mohamad, Parker, Claire E, MacDonald, John K, Khanna, Reena, Jairath, Vipul, Feagan, Brian G
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2020
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386457/
https://ncbi.nlm.nih.gov/pubmed/32413933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012877.pub2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker